泽璟制药 (688266.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(泽璟制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 384,117,191.62240,696,731.58108,244,408.58386,438,784.02282,104,804.49219,928,154.33108,110,475.27
 营业收入(元) 384,117,191.62240,696,731.58108,244,408.58386,438,784.02282,104,804.49219,928,154.33108,110,475.27
二、营业总成本(元) 509,620,185.43330,471,226.37158,939,244.62778,740,484.69541,758,673.77358,131,612.47176,481,152.90
 营业成本(元) 27,024,454.4317,495,980.987,149,214.5329,212,095.9521,449,337.7316,489,388.287,486,278.60
 研发费用(元) 272,787,045.80181,154,578.0484,346,541.11496,329,685.86335,190,822.91220,319,327.8791,892,329.58
 营业税金及附加(元) 867,445.09563,957.23235,709.791,023,163.55716,056.01488,991.85330,591.38
 销售费用(元) 189,668,174.67120,194,067.0360,109,621.60250,488,357.76172,193,131.08117,644,761.9655,465,899.48
 管理费用(元) 41,035,357.0926,420,304.1714,058,987.0416,560,957.7521,708,376.716,471,436.1921,649,276.13
 财务费用(元) -21,762,291.65-15,357,661.08-6,960,829.45-14,873,776.18-9,499,050.67-3,282,293.68-343,222.27
  其中:利息费用(元) 21,794,742.2615,346,029.697,012,285.5922,552,728.9716,308,154.5710,306,099.324,980,694.24
  其中:利息收入(元) 43,673,487.3530,781,852.0314,516,923.4839,354,994.8027,153,784.1614,353,635.825,746,159.40
三、其他经营收益
 加:公允价值变动收益(元) 3,902,701.583,613,934.102,481,810.548,725,963.907,794,419.122,429,032.66597,195.10
 加:投资收益(元) 2,407,009.091,561,941.83505,946.825,958,525.531,528,842.101,528,841.371,209,370.08
 信用减值损失(元) -3,158,148.94-3,059,245.63-572,773.26-1,619,378.03-1,015,098.48-1,977,320.65-263,234.90
 其他收益(元) 9,803,330.568,221,905.162,655,577.6581,454,190.9434,978,075.7614,062,036.026,460,560.93
四、营业利润(元) -112,548,101.52-79,435,959.33-45,624,274.29-297,782,398.33-216,367,630.78-122,160,868.74-60,366,786.42
 加:营业外收入(元) 3,681.42884.96442.484,955.764,955.762,477.88619.47
 减:营业外支出(元) 58,304.4358,301.69-1,307,069.11904,975.23583,961.23473,000.00
五、利润总额(元) -112,602,724.53-79,493,376.06-45,623,831.81-299,084,511.68-217,267,650.25-122,742,352.09-60,839,166.95
 减:所得税费用(元) -2,956,159.52-1,965,711.71-993,045.91-3,949,557.69-2,971,514.11-1,939,595.20-963,373.08
六、净利润(元) -109,646,565.01-77,527,664.35-44,630,785.90-295,134,953.99-214,296,136.14-120,802,756.89-59,875,793.87
(一)按经营持续性分类
  持续经营净利润(元) -109,646,565.01-77,527,664.35-44,630,785.90-295,134,953.99-214,296,136.14-120,802,756.89-59,875,793.87
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -97,902,983.29-66,536,070.99-39,499,383.01-278,582,744.17-202,089,409.77-114,228,726.64-57,227,635.33
  少数股东损益(元) -11,743,581.72-10,991,593.36-5,131,402.89-16,552,209.82-12,206,726.37-6,574,030.25-2,648,158.54
 扣除非经常性损益后的净利润(元) -104,556,818.63-72,371,226.25-42,502,883.55-348,745,151.79-243,280,684.53-130,009,579.67-63,921,861.10
七、每股收益
 一、基本每股收益(元) -0.37-0.25-0.15-1.09-0.80-0.46-0.24
 二、稀释每股收益(元) -0.37-0.25-0.15-1.09-0.80-0.46-0.24
八、其他综合收益(元) 26,035,078.95338,774.70104,914.23-2,670,887.432,096,126.562,588,560.46-1,035,491.19
 归属于母公司股东的其他综合收益(元) 24,168,674.87284,879.3979,994.91-3,108,162.471,403,393.621,668,389.19-629,827.26
 归属于少数股东的其他综合收益(元) 1,866,404.0853,895.3124,919.32437,275.04692,732.94920,171.27-405,663.93
九、综合收益总额(元) -83,611,486.06-77,188,889.65-44,525,871.67-297,805,841.42-212,200,009.58-118,214,196.43-60,911,285.06
 归属于母公司所有者的综合收益总额(元) -73,734,308.42-66,251,191.60-39,419,388.10-281,690,906.64-200,686,016.15-112,560,337.45-57,857,462.59
 归属于少数股东的综合收益总额(元) -9,877,177.64-10,937,698.05-5,106,483.57-16,114,934.78-11,513,993.43-5,653,858.98-3,053,822.47
公告日期 2024-10-262024-08-242024-04-202024-04-202023-10-282023-08-262023-04-22
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院